stage IV prostate cancer
Showing 1 - 25 of >10,000
Metastatic Prostate Carcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia
Not yet recruiting
- Metastatic Prostate Carcinoma
- +3 more
- Training and Education
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Dec 13, 2022
Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 Trial in San Francisco (Angiogram,
Recruiting
- Prostate Adenocarcinoma
- +9 more
- Angiogram
- +3 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 5, 2022
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Carcinoma Trial in Duarte (procedure, drug, other)
Not yet recruiting
- Advanced Prostate Carcinoma
- +4 more
- Bright White Light Therapy
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 8, 2023
Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C
Active, not recruiting
- Prostate Adenocarcinoma
- +9 more
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +5 more
- Questionnaire Administration
- Tin Sn 117m Pentetate
-
Lexington, KentuckyUniversity of Kentucky/Markey Cancer Center
Nov 26, 2022
Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen
Recruiting
- Castration-Resistant Prostate Carcinoma
- +7 more
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Screening for Prostate Cancer, GIFTS Study
Enrolling by invitation
- Metastatic Prostate Carcinoma
- +2 more
- Questionnaire
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 22, 2022
Sedentary Lifestyle, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Cancer AJCC v7 Trial in Salt Lake City (Cognitive
Active, not recruiting
- Sedentary Lifestyle
- +2 more
- Cognitive Behavior Therapy
- Exercise Intervention
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Jun 24, 2022
Metastatic Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial (Patient Navigation,
Not yet recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Patient Navigation
- +3 more
- (no location specified)
Aug 2, 2022
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United
Recruiting
- Hormone-Resistant Prostate Cancer
- +3 more
-
Ann Arbor, Michigan
- +3 more
Feb 2, 2023
Metastatic Prostate Cancer, Stage IIB Prostate Cancer, Stage IIC Prostate Cancer Trial in Philadelphia (Interview, Internet
Active, not recruiting
- Biochemically Recurrent Prostate Carcinoma
- +4 more
- Interview
- +5 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Oct 25, 2022
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium
Recruiting
- Advanced Malignant Solid Neoplasm
- +22 more
- TRPV6 Calcium Channel Inhibitor SOR-C13
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Image Guided Biopsy
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jun 17, 2022
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)
Recruiting
- Prostate Cancer
- Stage IV Prostate Cancer
- Luteinizing Hormone Releasing Hormone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jun 1, 2022
Urinary and Gut Microbiome During Androgen Deprivation Therapy
Suspended
- Stage I Prostate Cancer AJCC v7
- +5 more
- Biospecimen Collection
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston
Completed
- Castration-Resistant Prostate Carcinoma
- +5 more
- Durvalumab
- Tremelimumab
-
Houston, TexasM D Anderson Cancer Center
Nov 9, 2022
Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic
Not yet recruiting
- Metastatic Malignant Neoplasm in the Viscera
- +4 more
- Lutetium Lu 177 Dotatate
- (no location specified)
Jan 25, 2023
Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo
Recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Decitabine and Cedazuridine
- Enzalutamide
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 27, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Genetic Testing for Men With Metastatic Prostate Cancer
Recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Biospecimen Collection
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 9, 2022